- Home
- ACLS vs ARQT Comparison
ACLS vs ARQT Comparison
Compare ACLS & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- ARQT
- Stock Information
- Founded
- ACLS 1995
- ARQT 2016
- Country
- ACLS United States
- ARQT United States
- Employees
- ACLS N/A
- ARQT N/A
- Industry
- ACLS Industrial Machinery/Components
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- ACLS Technology
- ARQT Health Care
- Exchange
- ACLS Nasdaq
- ARQT Nasdaq
- Market Cap
- ACLS 1.8B
- ARQT 2.0B
- IPO Year
- ACLS 2000
- ARQT 2020
- Fundamental
- Price
- ACLS $42.42
- ARQT $14.73
- Analyst Decision
- ACLS Buy
- ARQT Strong Buy
- Analyst Count
- ACLS 7
- ARQT 6
- Target Price
- ACLS $156.00
- ARQT $18.80
- AVG Volume (30 Days)
- ACLS 665.4K
- ARQT 2.7M
- Earning Date
- ACLS 04-30-2025
- ARQT 05-13-2025
- Dividend Yield
- ACLS N/A
- ARQT N/A
- EPS Growth
- ACLS N/A
- ARQT N/A
- EPS
- ACLS 6.15
- ARQT N/A
- Revenue
- ACLS $1,017,865,000.00
- ARQT $196,542,000.00
- Revenue This Year
- ACLS N/A
- ARQT $56.84
- Revenue Next Year
- ACLS $11.97
- ARQT $44.87
- P/E Ratio
- ACLS $6.87
- ARQT N/A
- Revenue Growth
- ACLS N/A
- ARQT 229.74
- 52 Week Low
- ACLS $40.40
- ARQT $6.99
- 52 Week High
- ACLS $158.61
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- ACLS 21.08
- ARQT 46.22
- Support Level
- ACLS $47.23
- ARQT $14.51
- Resistance Level
- ACLS $51.38
- ARQT $17.43
- Average True Range (ATR)
- ACLS 2.28
- ARQT 1.17
- MACD
- ACLS -1.04
- ARQT -0.22
- Stochastic Oscillator
- ACLS 11.22
- ARQT 13.47
Stock Price Comparison Chart: ACLS vs ARQT
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.